MCK

SELL

McKesson Corporation

Healthcare · Rank #433 · Analyzed Apr 20, 2026

$866.38

Current Price

$0.00

Intrinsic Value

0.0%

Upside/Downside

1/10

Score

0.5/5

Quality

Analysis Summary

Valuation Consensus1/2 methods agree

Quality Score0.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 0.0%

Fair Value Range

Low$382.22

Base (IV)$0.00

High$11265.98

Entry Points

Conservative$382.22

Moderate$3953.89

Aggressive$7525.57

⚠️ Warnings

Upside capped: raw 1200% exceeds 200% — valuation unreliable

Quality & Moat Breakdown

Return on Equity0.0% → 0/1.0

Debt LevelD/E 100 → 0/1.0

Revenue QualityGrowth 16.8%, margin Δ-0.5% → 0.5/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins1.1% → 0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.